Global /China /Healthcare /Drug Manufacturers - General /000538

Yunnan Baiyao Group Co.,Ltd

000538

• SHE: 000538 • Delayed

53.05CNY -2.9%

7.84 USD

As of 10 June 2026, Yunnan Baiyao Group Co.,Ltd has a market cap of $14.4B USD, ranking #1618 globally and #238 in China. It ranks #121 in the Healthcare sector, and #49 in the Drug Manufacturers - General industry.

Global Rank

1618

Country Rank

238

Sector Rank

121

Industry Rank

Key Stats

Market Cap

$14.4BUSD

97.47B CNY

Enterprise Value

$12.47BUSD

84.39B CNY

Revenue (TTM)

$6.09BUSD

41.19B CNY

EBITDA (TTM)

$715.48MUSD

4.84B CNY

Net Income (TTM)

$761.58MUSD

5.15B CNY

EBITDA Margin

12%

Profit Margin

13%

PE Ratio

18.9

Forward PE

17.2

PS Ratio

2.4

PB Ratio

2.4

EV/EBITDA

17.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ming Dong open_in_new

Employees

9,286

Founded

1902

Website

yunnanbaiyao.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.9%	-2.3%	-2.5%	-5.4%	-5.9%	-6.5%	-8.1%	-8.8%	-35%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000538 云南白药集团股份有限公司 Class A ISIN: CNE0000008X7 Shares Out.: Shares Outstanding: 1.773B¹ Shares Float: 1.772B² TV: TradingView: SZSE: 000538 SA: Stock Analysis: SHE: 000538 YF: Yahoo Finance: 000538.SZ GF: Google Finance: SHE: 000538 BA: Barron's: 000538 MS: Morningstar: XSHE: 000538	53.05 CNY	TV: TradingView: SZSE: 000538 SA: Stock Analysis: SHE: 000538 YF: Yahoo Finance: 000538.SZ GF: Google Finance: SHE: 000538 BA: Barron's: 000538 MS: Morningstar: XSHE: 000538

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Yunnan Baiyao Group Co.,Ltd

Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmaceutical supply chain service solutions. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.92B 364.89B CNY 274%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.71B 336.36B CNY 245%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 98%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 30%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 15%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 11%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 5K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 4K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 2K%	97.4	United States
Roche Holding AG SIX: RO	$321.17B 256.25B CHF 2K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.57B 215.59B GBP 2K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.35B 218.9B CHF 2K%	20.5	Switzerland

chevron_leftBack